BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306 AND Treatment
11 results:

  • 1. Efficacy and safety of first-line immune checkpoint inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: A network meta-analysis.
    Wang S; Li Y; Liu Z; Tian W; Zeng Y; Liu J; Zhang S; Peng Y; Wu F
    Lung Cancer; 2023 Apr; 178():47-56. PubMed ID: 36774774
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A comprehensive bioinformatics analysis of FOXP3 in nonsmall cell lung cancer.
    Zhu J; Li Z; Chen J; Li W; Wang H; Jiang T; Ma Y
    Medicine (Baltimore); 2022 Dec; 101(50):e32102. PubMed ID: 36550816
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predictive value of tumor mutational burden for immunotherapy in non-small cell lung cancer: A systematic review and meta-analysis.
    Meng G; Liu X; Ma T; Lv D; Sun G
    PLoS One; 2022; 17(2):e0263629. PubMed ID: 35113949
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study.
    Wu CE; Chang CF; Huang CY; Yang CT; Kuo CS; Hsu PC; Chang JW
    BMC Cancer; 2021 Jul; 21(1):859. PubMed ID: 34315431
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment.
    Carbó JM; León TE; Font-Díaz J; De la Rosa JV; Castrillo A; Picard FR; Staudenraus D; Huber M; Cedó L; Escolà-Gil JC; Campos L; Bakiri L; Wagner EF; Caelles C; Stratmann T; Van Ginderachter JA; Valledor AF
    Cancer Res; 2021 Feb; 81(4):968-985. PubMed ID: 33361391
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Blocking P2X7-Mediated Macrophage Polarization Overcomes treatment Resistance in lung cancer.
    Qin J; Zhang X; Tan B; Zhang S; Yin C; Xue Q; Zhang Z; Ren H; Chen J; Liu M; Qian M; Du B
    Cancer Immunol Res; 2020 Nov; 8(11):1426-1439. PubMed ID: 32933967
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunobiochemical Reconstruction of Influenza lung Infection-Melanoma Skin cancer Interactions.
    Nikolaev EV; Zloza A; Sontag ED
    Front Immunol; 2019; 10():4. PubMed ID: 30745900
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
    Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
    Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CPEB4 and irf4 expression in peripheral mononuclear cells are potential prognostic factors for advanced lung cancer.
    Wu YY; Hwang YT; Perng WC; Chian CF; Ho CL; Lee SC; Chang H; Terng HJ; Chao TY
    J Formos Med Assoc; 2017 Feb; 116(2):114-122. PubMed ID: 27113098
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Role of STAT3 as a negative regulator in Mac2- binding protein expression.
    Park YP; Kim JT; Yang Y; Lim JS; Yoon DY; Kim JW; Lee HG
    Korean J Lab Med; 2008 Jun; 28(3):230-8. PubMed ID: 18594176
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Results of radiotherapy of bronchial carcinoma (author's transl)].
    Heilmann HP; Doppelfeld E; Fernholz HJ; Birkner R; Schlicker H; Becker G; Gordon-Harris L; Hackl A; Sager WD; Jentsch F; Kraft W; Bünemann H; Horstmann W; Hassenstein E; Kuttig H; Wieland C; Schmidt N; Müller A; Quäck J; Buchelt L; Hess F; Koop EA; von Lieven H; Heinze HG; Castrup W; Wannenmacher M; Rey G; Voss AC; Nüse A; Eibach E; Grund W; Bohndorf W; Schindler G
    Dtsch Med Wochenschr; 1976 Oct; 101(43):1557-62. PubMed ID: 62648
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.